Viewing StudyNCT01708174



Ignite Creation Date: 2024-05-06 @ 12:59 AM
Last Modification Date: 2024-10-26 @ 10:57 AM
Study NCT ID: NCT01708174
Status: COMPLETED
Last Update Posted: 2017-08-11
First Post: 2012-10-11

Brief Title: A Phase II Study of Oral LDE225 in Patients With Hedge-Hog Hh-Pathway Activated Relapsed Medulloblastoma MB
Sponsor: Novartis Pharmaceuticals
Organization: Novartis

Conditions & Keywords Data

Conditions:
Name
Medulloblastoma
Keywords:
Name View
LDE225 View
medulloblastoma View
relapsed View
pediatric View
children View
adults View
Hh pathway inhibitor View